The incidence, prevalence, and severity of sarcoidosis in New York City firefighters

Chest

Volumn 116, Issue 5, 1999, Pages 1183-1193

  Prezant, David J ^a,b,c   Dhala, Atheya ^b   Goldstein, Andrew ^d   Janus, Denise ^b   Ortiz, Felipe ^b   Aldrich, Thomas K ^b   Kelly, Kelly J ^a  

^a Government of New york   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

^d NONE

Author keywords

Exercise testing; Firefighters; Pulmonary function; Sarcoidosis

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ARTICLE; DISEASE SEVERITY; FIRE FIGHTER; HUMAN; LUNG FUNCTION; OCCUPATIONAL EXPOSURE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SARCOIDOSIS; UNITED STATES;

EID: 0032725068     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.5.1183     Document Type: Article

References (35)

1. 1 Tierstein AS, Lesser M. Worldwide distribution and epidemiology of sarcoidosis. In: Fanburg BL, ed. Sarcoidosis and other granulomatous diseases of the lung. New York, NY: Marcel Dekker, 1983; 101-134
2. 2 Parkes SA, Baker SB, Bourdillon RE, et al. Epidemiology of sarcoidosis in the Isle of Man: 1. A case controlled study. Thorax 1987; 42:420-426
3. 3 Hosoda Y, Yamaguchi M, Hiraga Y. Global epidemiology of sarcoidosis: what story do prevalence and incidence tell us? Clin Chest Med 1997; 18:681-694
4. 4 Bresnitz EA, Stolley PD, Isreal HL, et al. Possible risk factors for sarcoidosis: a case control study. Ann NY Acad Sci 1986; 465:632-642
5. 5 Bauer HJ, Lofgren S. International study of pulmonary sarcoidosis in mass chest radiography. Acta Med Scand 1964; 176(suppl425):103-105
6. 6 Levinsky L, Altmann V. Prevalence of pulmonary sarcoidosis in Czechoslovakia: proceedings of the Third International Conference on Sarcoidosis. Acta Med Scand 1964; (Suppl425); 176:171-173
7. 7 Bauer HJ, Wijkstrom S. The prevalence of pulmonary sarcoidosis in Swedish mass radiography surveys. Sundbybeerg, Sweden: Center of Mass Chest Radiography of the Royal Swedish Medical Boards, 1963; 112-114
8. 8 Logan J. Prevalence of sarcoidosis in Ireland: proceedings of the Third International Conference on Sarcoidosis. Acta Med Scand 1964; (Suppl425); 176:126
9. 9 Rybicki BA, Major M, Popovich J, et al. Racial differences in sarcoidosis incidence: a 5 year study in a health maintenance organization. Am J Epidemiol 1997; 145:234-241
10. 10 Robins AB, Abeles H, Chaves AD. Prevalence and demographic characteristics of sarcoidosis. Bureau of Tuberculosis, New York, NY: Department of Health, NY, 1962; 149-151
11. 11 National Institute for Occupational Safety, Centers for Disease Control: sarcoidosis among US Navy enlisted men; 1965-1993. MMWR 1997; 46:539-543
12. 12 Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol 1974; 99:250-257
13. 13 Gronhagen-Riska C, Saikku P, Riska H, et al. Antibodies to TWAR - a novel type of chlamydia - in sarcoidosis. In: Grassi C, Rizzato G, Pozzi E, eds. Sarcoidosis and other granulomatous disorders. Amsterdam, Holland: Elsevier Science Publishers, 1988; 297-300
14. 14 Almenoff PL, Johnson A, Lesser M, et al. Growth of acid fast L forms from the blood of patients with sarcoidosis. Thorax 1996; 51:530-533
15. 15 Nagai S, and Izumi T. Pulmonary sarcoidosis: population differences and pathophysiology. South Med J 1995; 88:1001-1010
16. 16 Edmonstone WM. Sarcoidosis in nurses: is there an association? Thorax 1988; 43:342-343
17. 17 Richeldi L, Kreiss K, Mroz MM, et al. Interaction of genetic and exposure factors in the prevalence of berylliosis. Am J Ind Med 1997; 32:337-340
18. 18 Kern DG, Neill MA, Wrenn DS, et al. Investigation of a unique time-space cluster of sarcoidosis in firefighters. Am Rev Respir Dis 1993; 148:974-980
19. 19 Siltzbach LS. Sarcoidosis: clinical features and management. Med Clin N Am 1967; 51:483
20. 20 Bates DV. Normal pulmonary function. In: Bates DV, ed. Respiratory function in disease. 3rd ed. Philadelphia, PA: WB Saunders, 1989; 106-151
21. 21 American Thoracic Society. Standardization of spirometry: 1987 update. Am Rev Respir Dis 1987; 136:1285-1289
22. 22 American Thoracic Society. Single breath carbon monoxide diffusion capacity (transfer factor): recommendations for standard technique. Am Rev Respir Dis 1987; 136:1299-1307
23. 23 Matthews JI, Hooper RG. Exercise testing in pulmonary sarcoidosis. Chest 1983; 83:75-81
24. 24 Miller A, Brown LK, Sloane MF, et al. Cardiorespiratory responses to incremental exercise in sarcoidosis patients with normal spirometry. Chest 1995; 107:323-329
25. 25 Shapiro GG, Bierman CW. Inhalation bronchoprovocation in children. In: Spector SL, ed. Provocative challenge procedures. Mount Kisco, NY: Futura Publishing, 1989; 405-410
26. 26 Jones NL, McHardy GJR, Naimark A, et al. Physiological dead space and alveolar-arterial gas pressure differences during exercise Clin Sci 1966; 31:19-29
27. 27 Wasserman K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation. 2nd ed. Philadelphia, PA: Lea & Febiger, 1994; 53-81
28. 28 Athos L, Mohler JG, Sharma OP. Exercise testing in the physiologic assessment of sarcoidosis. Ann NY Acad Sci 1986; 465:491-499
29. 29 Sietsama KE, Kraft M, Ginzton L, et al. Abnormal oxygen uptake responses to exercise in patients with mild pulmonary sarcoidosis. Chest 1992; 102:838-845
30. 30 Lacroniqu J, Auzeby A, Valeyre D, et al. Urinary neopterin in pulmonary sarcoidosis. Am Rev Respir Dis 1989; 139:1474-1478
31. 31 Harris J, Bartelson BB, Barker E, et al. Serum neopterin in chronic beryllium disease. Am J Ind Med 1997; 32:21-26
32. 32 Barnard RJ, Duncan HW. Heart rate and ECG responses in firefighters. J Occup Med. 1975; 17:247-250
33. 33 O'Connell ER, Thomas PC, Cady LD, et al. Energy costs of simulated stair climbing as a job-related task in fire fighting. J Occup Med 1986; 28:282-284
34. 34 Mannning JE, Griggs TR. Heart rates in firefighters using light and heavy breathing equipment: similar near-maximal exertion in response to multiple work load conditions. J Occup Med 1983; 25:215-218
35. 35 American Thoracic Society. Evaluation of impairment/disability secondary to respiratory disorders. Am Rev Respir Dis 1986; 133:1205-1209